Douglas Fisher, MD
“I have been involved with a number of women’s health companies, but none of them will impact patients’ lives more than Sera. Developing tests that predict pregnancy complications will enable improved disease management and benefit thousands, if not millions, of women and their babies.”
Dr. Fisher is a former partner of InterWest Partners, LLC, and served on Sera’s Board of Directors since the company’s Series A funding in November 2011. He joined Sera as its business and strategy development executive in January 2015 and continues to serve as an Executive-in-Residence at InterWest Partners. Dr. Fisher has focused on biopharmaceutical, diagnostic, and medical device investments throughout his career, working in venture capital, consulting, and pharmaceutical industries. He received his M.D. and M.B.A. from the School of Medicine and the Wharton School, respectively, at the University of Pennsylvania.